Seeking Alpha

forever5683

forever5683
Send Message
View forever5683's StockTalks BY TICKER:
  • forever5683
    $OXGN : Nov.10,2014 - OXGN confirmed that addition of Fosbretabulin to Bevacizumab SIGNIFICANTLY increase PFS in recurrent ovarian cancer
    Dec 17, 1:32 PM
    Reply (3)
  • View all 3 replies
    • forever5683: Shorter phase 3 trial or accelerate their early approval for Fosbretabulin; Inside OXGN acquiring more shares;
      Dec 17, 1:36 PM
    • forever5683: Fosbretabulin to Bevacizumab is non-chemotherapy; Its market size is worth $billion dollars; are reason for BO for OXGN in anytime soon.
      Dec 17, 1:37 PM
      • forever5683
        $OXGN any stock under $3 or less , easy to be manipulated. OXGN is good, if you grabbed some, then you are in a good luck.
        Dec 15, 10:50 AM
        Reply
          • forever5683
            $OXGN Dec.is, perhaps, the time for an announcement ; I think so and that those shorts would miss the ride when it happens. ; )
            Dec 2, 4:04 PM
            Reply
              • forever5683
                $OXGN with the approval from Roche, now expect OXGN partner or acquisition within 1~3 months. pt $5.50~$6.50
                Nov 17, 9:57 AM
                Reply
                  • forever5683
                    $OXGN Now with the FDA approval, OXGN has a better chance of getting their partner for 3phase.
                    Nov 14, 2:07 PM
                    Reply (1)
                    • forever5683: Partner news be another catalyst for OXGN, expecting its partner news within 1 month.
                      Nov 14, 2:21 PM
                      • forever5683
                        $OXGN http://seekingalpha.com/n/19myt
                        Nov 14, 2:02 PM
                        Reply (4)
                      • View all 4 replies
                        • forever5683: @Indian420 Let say, ROCHE's FDA approval was A+B and OXGN has A+C; A gets approved, but A+C works better than A alone, nice pathway for OX
                          Nov 14, 2:24 PM
                        • Indian420: thanks..hopefully partner news would be coming soon now..
                          Nov 15, 2:00 AM
                          • forever5683
                            $OXGN Pha. 2 Data Confirming - Addition of Fosbretabulin to Bevacizumab Significantly Increases Progression http://yhoo.it/1w9nAak
                            Nov 10, 6:44 AM
                            Reply
                              • forever5683
                                $APRI 3 upcoming conference 11/12 , 11/18, 12/4
                                Nov 7, 10:16 AM
                                Reply
                                  • forever5683
                                    $ICPT earning caused it to drop -20% today???
                                    Nov 7, 9:41 AM
                                    Reply (4)
                                  • View all 4 replies
                                    • Hoang6: But don't you think $5B is a bit too high for a R/D company?
                                      Nov 7, 10:14 AM
                                    • derrickthms182: Easy pick up right here. $180 has been it support a few times. Ride the wave!
                                      Nov 7, 11:10 AM
                                      • forever5683
                                        $AEZS BE patient, guys ~ : )
                                        Nov 4, 9:42 AM
                                        Reply (1)
                                        • Roids0777: I wonder when they are going to halt trading.
                                          Nov 5, 1:05 PM
                                          • forever5683
                                            $CNAT think it's good entry at $7. Bought
                                            Nov 3, 12:04 PM
                                            Reply
                                              • forever5683
                                                $APRI Launch of Its Novel Topical Treatment for Erectile Dysfunction in Belgium by Sandoz http://yhoo.it/1tzwTDz
                                                Nov 3, 10:14 AM
                                                Reply
                                                  • forever5683
                                                    $MNKD I would recommend sell ATM. There was no revenue, especially from Afrezza & Their cash holding is low. Correct me if I'm wrong.
                                                    Nov 3, 9:42 AM
                                                    Reply (2)
                                                    • forever5683: If you are LONG, then it probably not matter since u are betting on the sale of Afrezza. I think SHORT-will take their gain from $4s.
                                                      Nov 3, 9:45 AM
                                                    • $TSLA fan: $MnKd has been disappointing since approval...we will see ER today?
                                                      Nov 3, 4:45 PM
                                                      • forever5683
                                                        $PLUG Deploys GenDrive hydrogen fuel cells at new regional distribution center 10/29/2014
                                                        Oct 29, 9:12 AM
                                                        Reply
                                                          • forever5683
                                                            $AEZS with the FDA approval m.a. 11/5, could worth above at least $2.50 & AEZS-108 could be next catalyst; I think it's about to reveal.
                                                            Oct 29, 1:27 AM
                                                            Reply (9)
                                                          • View all 9 replies
                                                            • forever5683: get an approval, stock is already plunged too much; couldn't lose a lot from here. & AEZS-108 could take it up again in 1H2015.
                                                              Oct 29, 5:42 PM
                                                            • forever5683: include CHTP too, no risky one, already BO. DRtX and CHtp had only one FDA approved drug and only one they had. LOL : )
                                                              Oct 29, 5:45 PM
                                                              • forever5683
                                                                $APRI 28% up, Buy Out target???
                                                                Oct 17, 4:08 PM
                                                                Reply
                                                                  • forever5683
                                                                    $PLUG *3rd QTR report on Nov.12th , 857 GenDrive units were shipped in the third quarter, 450%increased compare to 2013,3rdQTR.
                                                                    Oct 17, 10:39 AM
                                                                    Reply (1)
                                                                    • forever5683: My bet is also that there is a possible they could announce sale agreement before their earning report or expansion in Asia.
                                                                      Oct 17, 10:40 AM
                                                                      • forever5683
                                                                        $OXGN 5% up AH, so excited to see its pt Price soon , my bet on $OXGN $APRI LONG~
                                                                        Oct 16, 5:36 PM
                                                                        Reply
                                                                          • forever5683
                                                                            $AEZS FDA date 11/5 or BEFORE; I think it will pass, if not, this would be my 1st one that I didn't predict it right. : ) good luck
                                                                            Oct 15, 10:49 AM
                                                                            Reply
                                                                              • forever5683
                                                                                $SRPT Sarepta Drug Could Benefit From Duchenne Muscular Dystrophy Patient Study http://bit.ly/1xL1ZaW
                                                                                Oct 13, 1:42 PM
                                                                                Reply (2)
                                                                                • matratra: SRPT- From $48 dollars high to current price around $18. This dog has not barked. Who cares for The street.com recommendation.
                                                                                  Oct 13, 2:31 PM
                                                                                • forever5683: SRPT people need to be educated 1st to invest; SRPT 144wk data was actually good, but the # shown on the data, investors didn't like it.
                                                                                  Oct 13, 2:37 PM